tiprankstipranks
Trending News
More News >
Medmira Inc (TSE:MIR)
:MIR

Medmira (MIR) Price & Analysis

Compare
38 Followers

MIR Stock Chart & Stats

C$0.07
C$0.01(8.70%)
At close: 4:00 PM EST
C$0.07
C$0.01(8.70%)

Medmira News

MIR FAQ

What was Medmira Inc’s price range in the past 12 months?
Medmira Inc lowest stock price was C$0.06 and its highest was C$0.14 in the past 12 months.
    What is Medmira Inc’s market cap?
    Medmira Inc’s market cap is C$45.61M.
      When is Medmira Inc’s upcoming earnings report date?
      Medmira Inc’s upcoming earnings report date is Apr 07, 2026 which is in 62 days.
        How were Medmira Inc’s earnings last quarter?
        Currently, no data Available
        Is Medmira Inc overvalued?
        According to Wall Street analysts Medmira Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Medmira Inc pay dividends?
          Medmira Inc does not currently pay dividends.
          What is Medmira Inc’s EPS estimate?
          Medmira Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Medmira Inc have?
          Medmira Inc has 701,730,600 shares outstanding.
            What happened to Medmira Inc’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Medmira Inc?
            Currently, no hedge funds are holding shares in TSE:MIR
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              Medmira Inc

              Medmira Inc. (MIR) is a Canadian biotechnology company primarily focused on the development and commercialization of rapid diagnostic tests for various infectious diseases. The company operates in the healthcare sector, specializing in point-of-care testing solutions that enable quick and accurate diagnosis of conditions such as HIV, Hepatitis, and other sexually transmitted infections. Medmira's core product offerings include its proprietary rapid test technologies, which are designed to provide reliable results with minimal equipment and training, catering to both clinical and non-clinical settings worldwide.

              Medmira (MIR) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              Covalon Technologies
              Microbix Biosystms
              Sernova
              NurExone Biologic
              Defence Therapeutics

              Options Prices

              Currently, No data available
              ---
              Popular Stocks